Kurin, Inc. Announces Large-Scale Manufacturing of Push-Button Needle | Company

SAN DIEGO–(BUSINESS WIRE)–Sept. 7, 2022–

Kurin, Inc., the inventor and manufacturer of the Kurin ® Blood Culture Collection Sets, announced that its previously mentioned Advance Safety Needle System ™ has entered full-scale production on its automated machine. The Advance Needle was tested in 2021, has been in use in Kurin accounts since last year, and is now widely available.

“We are pleased with the transition to automated manufacturing of the advanced safety needle, as market demand for alternative needles has been strong,” said Bob Rogers, CEO of Kurin, Inc. “Needle manufacturers have created significant supply chain stress with unprecedented backorders and price escalations.With our Advance needle, we can better control product availability for Kurin’s growing customer base, as well as meet demand. from strategic partners looking for their own push-button needle, and we are delighted that Advance has improved performance characteristics over traditional retraction-focused products.”

Kurin’s revolutionary approach to the problem of contaminated blood culture is an elegant, simple and intuitive design that requires no additional steps from the user. Kurin passively brushes off potential contaminants while collecting blood cultures. Kurin is a simply better and more durable approach to conventional mechanical diversion. Contaminated blood cultures are a significant problem, as around a third of positive results are false, exposing these patients to unnecessary antibiotics, prolonging hospital stays and impacting larger community health issues, such as resistance. antimicrobials and life-threatening infections caused by C difference..

About Kurin, Inc.

Kurin, Inc., a Certified Minority Business Enterprise (MBE), is focused on designing, developing, manufacturing, marketing and selling products that help healthcare providers reduce contaminated blood cultures. Kurin, manufactured in San Diego, Calif., has received 510(k) marketing clearance from the FDA. For more information about Kurin, visit the website at www.kurin.com.

Show source version on businesswire.com:https://www.businesswire.com/news/home/20220907005087/en/

CONTACT: Matt Heindel

Kurin, Inc.

858-752-9514

[email protected]

KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH MEDICAL SUPPLIES MEDICAL DEVICES

SOURCE: Kurin, Inc.

Copyright BusinessWire 2022.

PUBLISHED: 07/09/2022 06:00/DISC: 07/09/2022 06:02

http://www.businesswire.com/news/home/20220907005087/en

Copyright BusinessWire 2022.